Logo image of FRSH.CA

THE FRESH FACTORY BC LTD (FRSH.CA) Stock Fundamental Analysis

TSX-V:FRSH - TSX Venture Exchange - CA35805H1055 - Common Stock - Currency: CAD

0.9  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to FRSH. FRSH was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of FRSH have multiple concerns. While showing a medium growth rate, FRSH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FRSH has reported negative net income.
In the past year FRSH had a positive cash flow from operations.
FRSH had negative earnings in each of the past 5 years.
FRSH had negative operating cash flow in 4 of the past 5 years.
FRSH.CA Yearly Net Income VS EBIT VS OCF VS FCFFRSH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -4.4%
ROE -9.5%
ROIC N/A
ROA(3y)-27.72%
ROA(5y)-29.42%
ROE(3y)-57.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRSH.CA Yearly ROA, ROE, ROICFRSH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

In the last couple of years the Gross Margin of FRSH has grown nicely.
FRSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.97%
GM growth 5YN/A
FRSH.CA Yearly Profit, Operating, Gross MarginsFRSH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

1

2. Health

2.1 Basic Checks

FRSH does not have a ROIC to compare to the WACC, probably because it is not profitable.
FRSH has less shares outstanding than it did 1 year ago.
FRSH has a worse debt/assets ratio than last year.
FRSH.CA Yearly Shares OutstandingFRSH.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
FRSH.CA Yearly Total Debt VS Total AssetsFRSH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

FRSH has an Altman-Z score of 0.39. This is a bad value and indicates that FRSH is not financially healthy and even has some risk of bankruptcy.
FRSH has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 0.39
ROIC/WACCN/A
WACC7.99%
FRSH.CA Yearly LT Debt VS Equity VS FCFFRSH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M

2.3 Liquidity

FRSH has a Current Ratio of 1.21. This is a normal value and indicates that FRSH is financially healthy and should not expect problems in meeting its short term obligations.
FRSH has a Quick Ratio of 1.21. This is a bad value and indicates that FRSH is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.89
FRSH.CA Yearly Current Assets VS Current LiabilitesFRSH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

FRSH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.07%, which is quite impressive.
Looking at the last year, FRSH shows a very strong growth in Revenue. The Revenue has grown by 33.08%.
Measured over the past years, FRSH shows a very strong growth in Revenue. The Revenue has been growing by 36.62% on average per year.
EPS 1Y (TTM)63.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%361.9%
Revenue 1Y (TTM)33.08%
Revenue growth 3Y36.62%
Revenue growth 5YN/A
Sales Q2Q%27.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FRSH.CA Yearly Revenue VS EstimatesFRSH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FRSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRSH.CA Price Earnings VS Forward Price EarningsFRSH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.08
FRSH.CA Per share dataFRSH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FRSH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

THE FRESH FACTORY BC LTD

TSX-V:FRSH (8/8/2025, 7:00:00 PM)

0.9

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4%
Ins Owner ChangeN/A
Market Cap9.40M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF 2.76
P/B 0.78
P/tB 0.78
EV/EBITDA 8.08
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0.33
OCFY36.21%
SpS4.59
BVpS1.16
TBVpS1.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE -9.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.86%
FCFM N/A
ROA(3y)-27.72%
ROA(5y)-29.42%
ROE(3y)-57.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.97%
GM growth 5YN/A
F-Score4
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 157.91%
Cap/Sales 7.64%
Interest Coverage N/A
Cash Conversion 209.79%
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 0.89
Altman-Z 0.39
F-Score4
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)87.81%
Cap/Depr(5y)94.6%
Cap/Sales(3y)4.29%
Cap/Sales(5y)5.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%361.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.08%
Revenue growth 3Y36.62%
Revenue growth 5YN/A
Sales Q2Q%27.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y80.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y95.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y188.68%
OCF growth 3YN/A
OCF growth 5YN/A